GlaxoSmithKline, Johnson & Johnson, Pfizer, AstraZeneca and More Present at the 6th Compound Management & Integrity Conference in Philadelphia, PA

Pharma IQ News

An efficient and versatile compound management operation is essential for the success of all downstream processes in high throughput screening (HTS) and small molecule development. 
The 6th Compound Management & Integrity
 conference taking place September 20 – 22, 2010 will address issues concerned with improving both strategic and tactical aspects of compound management.

Topics to be discussed at the event include:

  • Leveraging best in class methodologies to improve quality control and compound purity
  • Apply acoustic dispensing as a way to avoid the drawbacks of undesired physical contact with the same sample
  • Support both HTS and multiple hit strategies with flexible processes to increase quality, performance and capability

Participating organisations include
Pfizer, Merck, AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Biogen, Sanofi-Aventis, The Scripps Research Instituteand more.

Attendees at this event will consist of compound management, sample management, compound library, lead generation, high throughput screening, assay development, pharmacokinetics, informatics, drug delivery, automation and process co-ordination.

Sponsors for this event are BioFocus, Computype, Nexus, Remp, Specs and Titian and Liconic Instruments.

For more information, visit the website or contact Karen Richardson at karen.richardson@iqpc.como  (646) 378 6034.

IQPC produces more than 1,500 events annually around the world, and continues to grow.  Founded in 1973, IQPC now has offices in major cities across five continents.  IQPC leverages a global research base of best practices to produce a cross industry of information-sharing forums.